期刊文献+

原发性高血压血管内皮损伤与TM、VWF、PAI-1的研究 被引量:4

The relationship between the variations of TM,VWF,PAI-1 and endothelium dysfunction in essential hypertension
在线阅读 下载PDF
导出
摘要 目的探讨内皮损伤的分子标志物与原发性高血压发生血栓性疾病的关系。方法应用酶联免疫吸附法(ELISA)分别测定98例原发性高血压患者和36例健康对照者血浆TM、VWF、PAI-1的水平变化。结果与正常对照组比较,1、2、3级高血压组VWF、PAI-1水平显著增高(P<0.05),2、3级高血压组TM水平显著增高(P<0.05),与1级高血压组比较,2、3级高血压组TM、VWF、PAI-1水平显著增高,(P<0.05)。结论原发性高血压病患者存在的血管内皮损伤、抗凝作用减弱、血小板粘附与聚集、纤溶活性的下降,可能是其并发心、脑血管血栓性并发症的原因之一。 Objective To investigate the relationship between the molecular markers of endothelial dysfunction and the complications of thromboembolism in essential hypertension (EH). Methods The plasma concentration of TM,VWF,PAI - 1 were measured by ELISA method in 98 patients with essential hypertension and 36 healthy controls. Results To be compared with healthy controls, the levels of plasma VWF,PAI- 1 were significantly higher in EH patients with grade 1,2,3 groups( P 〈0.05) ,the levels of plasma TM were significantly higher in EH patients with grade 2,3 groups ( P 〈0. 05 ). To be compared with grade 1 group,the levels of plasma TM,VWF,PAI - 1 were significantly higher in EH patients with grade 2,3 groups( P 〈0.05). Conclusion Essential hypertensive patients had endothelium dysfunction, anticoagulant reduction, platelet activation and impaired fibrinolysis,w.hich may be the pathogenesis of complications such as ischemic stroke,heart attacks.
作者 马宏 张七一
出处 《中原医刊》 2005年第19期3-5,共3页 Central Plains Medical Journal
  • 相关文献

参考文献8

  • 1王淑娟.关于选择血栓前状态实验诊断指标的建议[J].临床检验信息导报,1998,5(2):37-43. 被引量:25
  • 2Califano F, Giovanniello T, Pantone P, et al. Clinical importance of thrombomodulin serum levels. Eur Rev Med Pharmacol Sci, 2000,4:59~ 66.
  • 3Borawski J, Mysliwiec M. Soluble thrombomodulin: a marker of endothelial injury, an antithrombotic angent, or both? Med Sci Monit, 2001,7:785 ~ 786.
  • 4Sadler JE. Thrombomodulin structure and function. Thromb Haemost,1997,78:392 ~ 395.
  • 5Galatius SS , Wroblewski H, Vibeke BS, et al. Endothelin and Von Willebrand factor as parameters of endothelial function in idiopathic dilated cardiomyopathy : different stimuli for release before and after heart transplantation. Am Heart J, 1999,137:549 ~ 554.
  • 6Kloczko J, et al. Von Willebrand factor antigen and fibronection in essential hypertension. Thromb Res, 1995,79:331 ~ 336.
  • 7Blann AD, Dobrotova M, Kubisz P, et al. Von Willebrand factor, soluble P - selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis. Thromb Haemost, 1995,74 (2) :626 ~630.
  • 8Nofer JR, Tepel M, Kefrel B, et al. Low- density lipoproteins inhibit the Na^+/H^+ antiport in human platelets: a novel mechanism enhancing platelet activity in hypercholesterolemia. Circulation, 1997,95:1370 ~1377.

共引文献24

同被引文献88

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部